Acorda Therapeutics Inc. (ACOR)
NASDAQ: ACOR
· Real-Time Price · USD
0.66
-0.21 (-24.14%)
At close: Apr 03, 2024, 3:59 PM
Acorda Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 9.36M | 30.36M | 32.47M | 25.27M | 30.25M | 37.54M | 20.7M | 23.13M | 31.87M | 45.63M | 36.17M | 45.71M | 116.77M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | 255K | 255K | 255K | 510K | 255K | 255K | 255K | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 4.95M | 4.19M | 3.9M | 3.15M | 2.01M | -42.78M | 502K | 503K | 6.2M | 6.2M | 12.41M | 12.41M | 18.62M |
Receivables | 9.19M | 17.3M | 11.98M | 13.39M | 9.19M | 13.87M | 14.69M | 14.27M | 11.99M | 17M | 13.59M | 14.01M | 17.3M |
Inventory | 14.12M | 16.16M | 17.94M | 14.8M | 13.46M | 12.75M | 15.25M | 15.32M | 14.84M | 18.55M | 20.59M | 25.36M | 27.41M |
Other Current Assets | 2.45M | 10.98M | 10.48M | 10.63M | 4.07M | 11.08M | 7.82M | 10.69M | 1.86M | 7.57M | 13.37M | 14.98M | 15.18M |
Total Current Assets | 48.45M | 74.79M | 73.73M | 64.91M | 68.09M | 82.11M | 71.69M | 76.52M | 80.45M | 102.16M | 97.07M | 112.94M | 189.72M |
Property-Plant & Equipment | 5.83M | 6.3M | 6.71M | 6.93M | 7.41M | 7.89M | 8.37M | 8.81M | 9.26M | 11.13M | 12.88M | 14.66M | 16.46M |
Goodwill & Intangibles | 22.34M | 22.99M | 282.01M | 289.7M | 297.39M | 305.09M | 312.78M | 320.47M | 328.23M | 335.98M | 343.73M | 351.48M | 359.25M |
Total Long-Term Assets | 33.12M | 42.95M | 292.62M | 299.78M | 306.81M | 313.48M | 321.65M | 329.79M | 343.68M | 353.31M | 369.02M | 378.56M | 394.33M |
Total Assets | 81.58M | 117.75M | 366.34M | 364.7M | 374.91M | 395.6M | 393.34M | 406.31M | 424.14M | 455.47M | 466.09M | 491.5M | 584.05M |
Account Payables | 9.93M | 13.37M | 12.33M | 3.17M | 2.85M | 10.09M | 11.51M | 7.96M | 8.77M | 11.81M | 15.5M | 17.48M | 9.49M |
Deferred Revenue | 294K | 227K | 465K | 548K | n/a | 384K | n/a | n/a | n/a | 27.64M | 34.16M | 28.81M | 38.12M |
Short-Term Debt | 193.07M | 187.73M | 1.58M | 1.57M | 1.56M | 1.54M | 1.45M | 1.35M | 7.04M | 8.19M | 9.32M | 10.71M | 74.73M |
Other Current Liabilities | 20.64M | 26.44M | 31.92M | 25.1M | 30.33M | 25.93M | 29.06M | 31.82M | 30.2M | 6.39M | 9.3M | 10.66M | 10.71M |
Total Current Liabilities | 223.94M | 227.77M | 46.29M | 30.39M | 34.74M | 37.95M | 42.02M | 41.12M | 46M | 54.02M | 68.27M | 68.27M | 133.05M |
Long-Term Debt | 2.85M | 3.17M | 184.51M | 179.93M | 175.55M | 171.37M | 192.3M | 189.87M | 186.31M | 182.76M | 179.66M | 176.37M | 178.18M |
Other Long-Term Liabilities | 40.56M | 35.54M | 38.04M | 46.96M | 45.85M | 48.45M | 41.02M | 46.6M | 50.09M | 53.59M | 41.44M | 41.88M | 49.62M |
Total Long-Term Liabilities | 43.41M | 47.93M | 261.09M | 266.44M | 263.21M | 264.02M | 275.55M | 277.29M | 250.59M | 250.31M | 233.34M | 232.75M | 244.72M |
Total Liabilities | 267.35M | 275.7M | 307.39M | 296.83M | 297.95M | 301.97M | 317.57M | 318.4M | 296.59M | 304.33M | 301.61M | 301.02M | 377.77M |
Total Debt | 195.92M | 190.9M | 186.09M | 181.5M | 177.11M | 172.92M | 193.75M | 191.22M | 193.34M | 190.94M | 188.98M | 187.07M | 252.91M |
Common Stock | 1K | 1K | 1K | 1K | 24K | 24K | 24K | 24K | 13K | 13K | 11K | 11K | 9K |
Retained Earnings | -1.22B | -1.19B | -971.37M | -962.48M | -953.1M | -936.27M | -955.41M | -941.56M | -894.88M | -870.36M | -849.79M | -822.72M | -799.86M |
Comprehensive Income | 875K | 1.43M | 717K | 880K | 719K | 628K | 2.09M | 738K | -568K | -1.02M | -1.56M | -1.83M | -1.73M |
Shareholders Equity | -185.77M | -157.96M | 58.96M | 67.87M | 76.96M | 93.62M | 75.77M | 87.91M | 127.55M | 151.14M | 164.47M | 190.48M | 206.28M |
Total Investments | n/a | 255K | 255K | 255K | 510K | 255K | 255K | 255K | n/a | n/a | n/a | n/a | n/a |